INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

CUSIP: 45773H409

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
66,777,963
Total 13F shares
33,075,457
Share change
+12,371,821
Total reported value
$57,545,189
Put/Call ratio
13%
Price per share
$1.74
Number of holders
98
Value change
+$21,224,322
Number of buys
43
Number of sells
39

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13D/G 13F
Company
15%
9,846,664
$19,200,995 $0 28 Nov 2025
JANUS HENDERSON GROUP PLC
13D/G 13F
Company
10%
6,666,295
$12,999,275 +$6,630,068 28 Nov 2025
Adage Capital Management, L.P.
13D/G
10%
5,517,650
$12,911,301 $0 30 Sep 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
5.1%
3,428,571
$8,022,856 30 Sep 2025
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13D/G
9.2%
3,633,333
$6,794,333 $0 31 Dec 2024
Alyeska Investment Group, L.P.
13D/G
6%
4,000,000
$6,400,000 $0 31 Dec 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
5%
from 13D/G
2,712,872
$6,348,120 30 Sep 2025
Boxer Capital Management, LLC
13F
Company
3.4%
2,300,000
$5,382,000 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3%
1,972,518
$4,615,692 30 Sep 2025
13F
Deep Track Capital, LP
13D/G
2.4%
1,314,796
$3,076,623 $0 30 Sep 2025
Stonepine Capital Management, LLC
13D/G
3.8%
1,434,997
$2,683,444 -$900,721 31 Mar 2025
Jong Joseph Kim
3/4/5
Chief Executive Officer, Director
mixed-class rows
3,113,086
mixed-class rows
$2,451,149 11 Mar 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.2%
816,339
$1,910,233 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.2%
806,742
$1,887,776 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
1.2%
786,774
$1,841,053 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.95%
636,061
$1,488,383 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.82%
546,747
$1,279,649 30 Sep 2025
13F
BlackRock, Inc.
13F 13D/G
Company
1.5%
from 13D/G
499,403
$1,168,603 30 Sep 2025
GSA CAPITAL PARTNERS LLP
13F
Company
0.66%
443,104
$1,037,000 30 Sep 2025
13F
UBS Group AG
13F
Company
0.44%
293,062
$685,765 30 Sep 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.44%
290,800
$680,472 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.36%
238,471
$558,022 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
0.32%
210,567
$492,727 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.28%
186,210
$435,731 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.25%
165,408
$387,000 30 Sep 2025
13F
GMT CAPITAL CORP
13F
Company
0.19%
126,119
$295,118 30 Sep 2025
13F
Headlands Technologies LLC
13F
Company
0.16%
110,068
$257,559 30 Sep 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.16%
108,701
$254,360 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.1%
65,206
$152,583 30 Sep 2025
13F
HRT FINANCIAL LP
13F
Company
0.1%
65,065
$152,000 30 Sep 2025
13F
Concurrent Investment Advisors, LLC
13F
Company
0.08%
56,011
$131,066 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
53,711
$125,683 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.08%
51,182
$119,766 30 Sep 2025
13F
Green Alpha Advisors, LLC
13F
Company
0.07%
48,088
$112,526 30 Sep 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
37,991
$89,057 30 Sep 2025
13F
Quadrature Capital Ltd
13F
Company
0.06%
37,115
$86,849 30 Sep 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.05%
33,496
$78,381 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
32,106
$75,128 30 Sep 2025
13F
LPL Financial LLC
13F
Company
0.04%
25,995
$60,828 30 Sep 2025
13F
Simon X. Benito
3/4/5
Director
mixed-class rows
17,275
mixed-class rows
$51,120 21 May 2025
Greenwich Wealth Management LLC
13F
Company
0.03%
20,399
$48,000 30 Sep 2025
13F
Wendy L. Yarno
3/4/5
Director
mixed-class rows
15,596
mixed-class rows
$47,980 21 May 2025
Ann C. Miller
3/4/5
Director
mixed-class rows
14,961
mixed-class rows
$46,792 21 May 2025
Jay Shepard
3/4/5
Director
mixed-class rows
14,293
mixed-class rows
$45,543 21 May 2025
ZACKS INVESTMENT MANAGEMENT
13F
Company
0.03%
19,455
$45,525 30 Sep 2025
13F
Roger D. Dansey
3/4/5
Director
mixed-class rows
14,000
mixed-class rows
$44,995 21 May 2025
Lota S. Zoth
3/4/5
Director
mixed-class rows
13,810
mixed-class rows
$44,640 21 May 2025
Prime Capital Investment Advisors, LLC
13F
Company
0.03%
18,453
$43,180 30 Sep 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.03%
17,673
$41,355 30 Sep 2025
13F
BANK OF MONTREAL /CAN/
13F
Company
0.03%
17,382
$40,674 30 Sep 2025
13F

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q4 2025

As of 31 Dec 2025, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,075,457 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Boxer Capital Management, LLC, D. E. Shaw & Co., Inc., ADAR1 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc.. This page lists 98 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
98
Q4 2025 holders
98
Holder diff
0
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.